Company news

Sensus Healthcare, Inc. (NASDAQ:SRTS) news

Sensus Healthcare, Inc. news releases on 6ix. Latest, Aug 13, 2026: Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare, Inc. (NASDAQ:SRTS) news

Press releases & updates

Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology

Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology

Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer

Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026

Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco

Sensus Healthcare Appoints Larry Biscotti to its Board of Directors

Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer

Sensus Healthcare Appoints Eric Sachetta to its Board of Directors

Sensus Healthcare Reports Third Quarter 2025 Financial Results

Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026

CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer

Sensus Healthcare Announces the Passing of Director Bill McCall

Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6

Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids

Sensus Healthcare Reports Second Quarter 2025 Financial Results

Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7

Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts

Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists

Sensus Healthcare Reports First Quarter 2025 Financial Results

Sensus Healthcare Celebrates Skin Cancer Awareness Month by Promoting Awareness and Spotlighting its Patient-Friendly, Non-Invasive Treatments

Sensus Healthcare to Report First Quarter 2025 Financial Results and Hold Business Update Conference Call on May 15

Sensus Healthcare to Participate in the 37th Annual ROTH Conference

Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting

Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence

Sensus Healthcare Buys Back Shares

Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results

Sensus Healthcare to Present at The Microcap Conference 2025

Sensus Healthcare to Report 2024 Fourth Quarter and Full Year Financial Results and Hold Business Update Conference Call on Wednesday, February 5, 2025

Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

Sensus Healthcare Sells SRT System to Providence Swedish Hospital

Sensus Healthcare Reports Second Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Second Quarter

Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024

Sensus Healthcare to Host Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 8, 2024

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities